Webinar
17
Oct
2022
2022
18
00
CEST
CEST
Diagnosis of drug induced Interstitial Lung Disease (ILD) in cancer patients: tips for practice
This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the fourth phase of the project will focus on the results emerged from the discussion on the new strategies to tackle adverse events on Interstitial Lung Disease Cancer.
Speakers

Discussant
Addeo Alfredo
Oncology Division, University Hospital Geneva, Geneve, Switzerland

Discussant
Rugo Hope
Winterhof Family Professor of Breast Cancer Director, Breast Oncology and Clinical Trials Education Medical Director, Cancer Infusion Services, San Francisco, USA

Expert
Bendstrup Elisabeth
Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark

Expert
Schaefer-Prokop Cornelia
Radiologist at Meander Medical Centre, Amersfoort, The Netherlands
This material is part of Educational
Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project